Skip to main content
. 2022 Jul 21;14(7):1511. doi: 10.3390/pharmaceutics14071511

Table 2.

The synergistic inhibition of coronaviral replication in HCoV-OC43-infected MRC-5 cells and SARS-CoV-2-infected Vero E6 cells after treatment with the combination of ciclesonide and dbq33b.

CoV Inhibition/Cell Line Synergy Score Most Synergistic Area Score Method
HCoV-OC43/HCT-8 15.10 ± 5.40 * 16.28 ZIP
SARS-CoV-2/Vero E6 14.37 ± 2.76 18.38 ZIP

* AVE ± S.D. of synergy scores from three independent experiments. Synergy scores were calculated and analyzed by SynergyFinder, ZIP method.